Form EFFECT BioLineRx Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 2, 2026 4:30 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Valor Gold Announces Passing of CEO Mark Ashley and Appointment of Interim CEO
- Hyperscale Data Sets November 12 as Investor Day to Discuss Michigan AI Expansion and Strategic Alternatives Across Its Portfolio
- Walker & Dunlop Arranges $630 Million Refinance for IMT Portfolio
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
